C. Rouzer and L. Marnett, Cyclooxygenases: structural and functional insights, The Journal of Lipid Research, vol.50, issue.Supplement, pp.29-34, 2009.
DOI : 10.1194/jlr.R800042-JLR200
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674713

N. Chandrasekharan, H. Dai, K. Roos, N. Evanson, and J. Tomsik, COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression, Proceedings of the National Academy of Sciences, vol.99, issue.21, pp.13926-13931, 2002.
DOI : 10.1073/pnas.162468699

B. Kis, J. Snipes, T. Isse, K. Nagy, and D. Busija, Putative Cyclooxygenase-3 Expression in Rat Brain Cells, Journal of Cerebral Blood Flow & Metabolism, vol.361, pp.1287-1292, 2003.
DOI : 10.1097/01.WCB.0000090681.07515.81

L. Crofford, COX-1 and COX-2 tissue expression: implications and predictions, J Rheumatol, vol.49, pp.15-19, 1997.

P. Kam and A. See, Cyclo-oxygenase isoenzymes: physiological and pharmacological role, Anaesthesia, vol.93, issue.(Suppl. 9), pp.442-449, 2000.
DOI : 10.1046/j.1365-2044.2000.01271.x

J. Martel-pelletier, J. Pelletier, and H. Fahmi, Cyclooxygenase-2 and prostaglandins in articular tissues, Seminars in Arthritis and Rheumatism, vol.33, issue.3, pp.155-167, 2003.
DOI : 10.1016/S0049-0172(03)00134-3

L. Zhang, A. Bertucci, K. Smith, L. Xu, and S. Datta, Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus, Arthritis & Rheumatism, vol.173, issue.12, pp.4132-4141, 2007.
DOI : 10.1002/art.23054

A. Giulietti, E. Van-etten, L. Overbergh, K. Stoffels, and R. Bouillon, Monocytes from type 2 diabetic patients have a pro-inflammatory profile, Diabetes Research and Clinical Practice, vol.77, issue.1, pp.47-57, 2007.
DOI : 10.1016/j.diabres.2006.10.007

X. Zhao, M. Goswami, N. Pokhriyal, H. Ma, and H. Du, Cyclooxygenase-2 Expression during Immortalization and Breast Cancer Progression, Cancer Research, vol.68, issue.2, pp.467-475, 2008.
DOI : 10.1158/0008-5472.CAN-07-0782

Y. Cai, Y. Lee, G. Li, S. Liu, and B. Bao, A new prostate cancer therapeutic approach: Combination of androgen ablation with COX-2 inhibitor, International Journal of Cancer, vol.119, issue.1, pp.195-201, 2008.
DOI : 10.1002/ijc.23481

H. Davenport, Salicylate Damage to the Gastric Mucosal Barrier, New England Journal of Medicine, vol.276, issue.23, pp.1307-1312, 1967.
DOI : 10.1056/NEJM196706082762308

L. Marnett, The COXIB Experience: A Look in the Rearview Mirror, Annual Review of Pharmacology and Toxicology, vol.49, issue.1, pp.265-290, 2009.
DOI : 10.1146/annurev.pharmtox.011008.145638

S. Chrubasik, O. Kunzel, A. Model, C. Conradt, and A. Black, Treatment of low back pain with a herbal or synthetic anti-rheumatic: a randomized controlled study. Willow bark extract for low back pain, Rheumatology, vol.40, issue.12, pp.1388-1393, 2001.
DOI : 10.1093/rheumatology/40.12.1388

G. Cravotto, L. Boffa, L. Genzini, and D. Garella, Phytotherapeutics: an evaluation of the potential of 1000 plants, Journal of Clinical Pharmacy and Therapeutics, vol.17, issue.Suppl. 2, pp.11-48, 2010.
DOI : 10.1111/j.1365-2710.2009.01096.x

P. Bock, W. Friedel, J. Hanisch, M. Karasmann, and B. Schneider, Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland], Arzneimittelforschung, vol.54, pp.456-466, 2004.

R. Klopp, W. Schmidt, E. Werner, M. Werner, and W. Niemer, Influence of complementary Viscum album (Iscador) administration on microcirculation and immune system of ear, nose and throat carcinoma patients treated with radiation and chemotherapy, Anticancer Res, vol.25, pp.601-610, 2005.

O. Christen-clottu, P. Klocke, D. Burger, R. Straub, and V. Gerber, Treatment of Clinically Diagnosed Equine Sarcoid with a Mistletoe Extract (Viscum album austriacus), Journal of Veterinary Internal Medicine, vol.269, issue.(1), pp.1483-1489, 2010.
DOI : 10.1111/j.1939-1676.2010.0597.x

G. Kienle and H. Kiene, Review Article: Influence of Viscum album L (European Mistletoe) Extracts on Quality of Life in Cancer Patients: A Systematic Review of Controlled Clinical Studies, Integrative Cancer Therapies, vol.2, issue.1, pp.142-157, 2010.
DOI : 10.1177/1534735410369673

K. Tusenius, A. Spoek, and J. Van-hattum, Exploratory Study on the Effects of Treatment with Two Mistletoe Preparations on Chronic Hepatitis C, Arzneimittelforschung, vol.55, issue.12, pp.749-753, 2005.
DOI : 10.1055/s-0031-1296925

A. Bussing, M. Bischof, W. Hatzmann, F. Bartsch, and D. Soto-vera, Prevention of surgeryinduced suppression of granulocyte function by intravenous application of a fermented extract from Viscum album L. in breast cancer patients, Anticancer Res, vol.25, pp.4753-4757, 2005.

A. Bussing and M. Schietzel, Apoptosis-inducing properties of Viscum album L. extracts from different host trees, correlate with their content of toxic mistletoe lectins, Anticancer Res, vol.19, pp.23-28, 1999.

D. Van-huyen, J. Bayry, J. Delignat, S. Gaston, A. Michel et al., Induction of apoptosis of endothelial cells by Viscum album: a role for anti-tumoral properties of mistletoe lectins, Mol Med, vol.8, pp.600-606, 2002.

D. Van-huyen, J. Delignat, S. Bayry, J. Kazatchkine, M. Bruneval et al., Interleukin-12 is associated with the in vivo anti-tumor effect of mistletoe extracts in B16 mouse melanoma, Cancer Letters, vol.243, issue.1, pp.32-37, 2006.
DOI : 10.1016/j.canlet.2005.11.016

D. Van-huyen, J. Delignat, S. Kazatchkine, M. Kaveri, and S. , Comparative Study of the Sensitivity of Lymphoblastoid and Transformed Monocytic Cell Lines to the Cytotoxic Effects of <i>Viscum album</i> Extracts of Different Origin, Chemotherapy, vol.49, issue.6, pp.298-302, 2003.
DOI : 10.1159/000074530

D. Van-huyensooryanarayana, J. Delignat, S. Bloch, M. Kazatchkine, and M. , Variable Sensitivity of Lymphoblastoid Cells to Apoptosis Induced by <i>Viscum album</i> Qu FrF, a Therapeutic Preparation of Mistletoe Lectin, Chemotherapy, vol.47, issue.5, pp.366-376, 2001.
DOI : 10.1159/000048545

S. Elluru, D. Van-huyen, J. Delignat, S. Prost, F. Bayry et al., Molecular Mechanisms Underlying the Immunomodulatory Effects of Mistletoe (Viscum album L.) Extracts Iscador, Arzneimittelforschung, vol.56, issue.06, pp.461-466, 2006.
DOI : 10.1055/s-0031-1296813

S. Elluru, J. Duong-van-huyen, S. Delignat, M. Kazatchkine, and A. Friboulet, Induction of maturation and activation of human dendritic cells: A mechanism underlying the beneficial effect of Viscum albumas complimentary therapy in cancer, BMC Cancer, vol.210, issue.9, pp.161-171, 2008.
DOI : 10.1016/j.imbio.2005.07.004

S. Elluru, D. Van-huyen, J. Delignat, S. Prost, F. Heudes et al., Antiangiogenic properties of viscum album extracts are associated with endothelial cytotoxicity, Anticancer Res, vol.29, pp.2945-2950, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00409601

K. Hostanska, T. Hajto, G. Spagnoli, J. Fischer, and H. Lentzen, A plant lectin derived from Viscum album induces cytokine gene expression and protein production in cultures of human peripheral blood mononuclear cells, Nat Immun, vol.14, pp.295-304, 1995.

P. Hegde, M. Maddur, A. Friboulet, J. Bayry, and S. Kaveri, Viscum album Exerts Anti-Inflammatory Effect by Selectively Inhibiting Cytokine-Induced Expression of Cyclooxygenase-2, PLoS ONE, vol.35, issue.10, p.22028854, 2011.
DOI : 10.1371/journal.pone.0026312.t001
URL : https://hal.archives-ouvertes.fr/hal-00637405

A. Ristimaki, S. Garfinkel, J. Wessendorf, T. Maciag, and T. Hla, Induction of cyclooxygenase-2 by inter- leukin-1 alpha. Evidence for post-transcriptional regulation, J Biol Chem, vol.269, pp.11769-11775, 1994.

C. Cerella, C. Sobolewski, M. Dicato, and M. Diederich, Targeting COX-2 expression by natural compounds: A promising alternative strategy to synthetic COX-2 inhibitors for cancer chemoprevention and therapy, Biochemical Pharmacology, vol.80, issue.12, p.20615394, 2010.
DOI : 10.1016/j.bcp.2010.06.050

X. Tong, R. Van-dross, A. Abu-yousif, A. Morrison, and J. Pelling, Apigenin Prevents UVB-Induced Cyclooxygenase 2 Expression: Coupled mRNA Stabilization and Translational Inhibition, Molecular and Cellular Biology, vol.27, issue.1, pp.283-296, 2007.
DOI : 10.1128/MCB.01282-06

M. Tamura, S. Sebastian, S. Yang, B. Gurates, and Z. Fang, Interleukin-1beta elevates cyclooxy- genase-2 protein level and enzyme activity via increasing its mRNA stability in human endometrial stromal cells: an effect mediated by extracellularly regulated kinases 1 and 2, J Clin Endocrinol Metab, vol.87, pp.3263-3273, 2002.

T. Tetsuka, L. Baier, and A. Morrison, Antioxidants Inhibit Interleukin-1-induced Cyclooxygenase and Nitric-oxide Synthase Expression in Rat Mesangial Cells: EVIDENCE FOR POST-TRANSCRIPTIONAL REGULATION, Journal of Biological Chemistry, vol.271, issue.20, pp.11689-11693, 1996.
DOI : 10.1074/jbc.271.20.11689

K. Chun and Y. Surh, Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention, Biochemical Pharmacology, vol.68, issue.6, pp.1089-1100, 2004.
DOI : 10.1016/j.bcp.2004.05.031

Y. Surh and J. Kundu, Signal transduction network leading to COX-2 Induction: a road map in search of cancer chemopreventives, Archives of Pharmacal Research, vol.62, issue.2, pp.1-15, 2005.
DOI : 10.1007/BF02975128

J. Kundu, H. Na, K. Chun, Y. Kim, and S. Lee, Inhibition of phorbol ester-induced COX-2 expression by epigallocatechin gallate in mouse skin and cultured human mammary epithelial cells, J Nutr, vol.133, pp.3805-3810, 2003.

S. Shrotriya, J. Kundu, H. Na, and Y. Surh, Diallyl Trisulfide Inhibits Phorbol Ester-Induced Tumor Promotion, Activation of AP-1, and Expression of COX-2 in Mouse Skin by Blocking JNK and Akt Signaling, Cancer Research, vol.70, issue.5, pp.1932-1940, 2010.
DOI : 10.1158/0008-5472.CAN-09-3501